Special items: Ovarian Cancer and Us blog best viewed in Firefox

Thursday, December 03, 2009

Drug company contributes $9 million to B.C.'s fight against cancer

Research in ovarian cancer will focus on identifying new biomarkers for diagnostic purposes as well as therapeutic targets

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.